Skip to main content

Table 1 Clinical characteristics of the critically ill ICU patients assessed

From: B and T lymphocyte attenuator expression on CD4+ T-cells associates with sepsis and subsequent infections in ICU patients

 

SIRS (n = 28)

Sepsis (n = 11)

Age

59.8 (3.8)

58.4 (7.2)

Male gender

17 (60.7%)

6 (54.5%)

APACHE II score

16.6 (4 to 29)

20.0 (5 to 26)

Patients from trauma ICU

11 (39.3%)

5 (45.4%)

Patients from surgical ICU

17 (60.7%)

6 (54.6%)

Average hospital length of stay (days)

31.1 (5.1)

58.4* (10.5)

Site of infection

  

 Lung

 

5 (45.4%)

 Blood

 

2 (18.2%)

 Abdominal

 

1 (9.1%)

 Urinary tract

 

1 (9.1%)

 Skin

 

1 (9.1%)

 Catheter

 

1 (9.1%)

Subsequent nosocomial infection

11 (39.2%)

8 (72.7%)

Site of infection

  

 Lung

3 (27.3%)

4 (50%)

 Abdominal

1 (9.1%)

0 (0%)

 Urinary tract

5 (45.4%)

3 (37.5%)

 Skin

2 (18.2%)

1 (10%)

Sampling time following ICU admission (days)

4 (0 to 45)

21 (3 to 83)

Days following subsequent infection

  

 Following ICU admission

 

31.7 (9 to 94)

 Following sampling

 

22.38 (6 to 49)

  1. Data presented as mean (standard error of the mean), number (%) or median (range). APACHE, Acute Physiology and Chronic Health Evaluation; SIRS, systemic inflammatory response syndrome. *P <0.05 via an unpaired, two-tailed Student’s t test.